Stability Indicating HPLC-ECD Method for the Analysis of Clarithromycin in Pharmaceutical Dosage Forms: Method Scaling versus Re-Validation

Pedzisai A. Makoni, Mellisa T. R. Chikukwa, Sandile M. M. Khamanga, Roderick B. Walker

Open source

DOI
10.3390/scipharm87040031
Published
2019-11-16
Container
Scientia Pharmaceutica
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/scipharm87040031,
  title = {Stability Indicating HPLC-ECD Method for the Analysis of Clarithromycin in Pharmaceutical Dosage Forms: Method Scaling versus Re-Validation},
  author = {Pedzisai A. Makoni and Mellisa T. R. Chikukwa and Sandile M. M. Khamanga and Roderick B. Walker},
  year = {2019},
  journal = {Scientia Pharmaceutica},
  doi = {10.3390/scipharm87040031},
  url = {https://doi.org/10.3390/scipharm87040031}
}

RIS

TY  - JOUR
TI  - Stability Indicating HPLC-ECD Method for the Analysis of Clarithromycin in Pharmaceutical Dosage Forms: Method Scaling versus Re-Validation
AU  - Pedzisai A. Makoni
AU  - Mellisa T. R. Chikukwa
AU  - Sandile M. M. Khamanga
AU  - Roderick B. Walker
PY  - 2019
JO  - Scientia Pharmaceutica
DO  - 10.3390/scipharm87040031
UR  - https://doi.org/10.3390/scipharm87040031
ER  - 

APA

Makoni, P. A., Chikukwa, M. T. R., Khamanga, S. M. M., & Walker, R. B. (2019). Stability Indicating HPLC-ECD Method for the Analysis of Clarithromycin in Pharmaceutical Dosage Forms: Method Scaling versus Re-Validation. Scientia Pharmaceutica. https://doi.org/10.3390/scipharm87040031

Source records